Jennifer Rymer is a consultant for Abbott. J. Dawn Abbott is on the advisory board of Medtronic and a consultant for Medtronic, Abbott, Penumbra, and Recor Medical. Ziad A. Ali is a consultant for Abiomed, AstraZeneca, Boston Scientific, Cathworks, Opsens, Philips, and Shockwave Medical; reports honoraria from Abiomed, Astra Zeneca, Boston Scientific, CathWorks, Opsens, Philips, and Shockwave; and holds stocks in Elucid, Lifelink, SpectraWAVE, Shockwave Medical, and VitalConnect. Mir B. Basir is a consultant for Abiomed, Boston Scientific, Chiesi, Saranas, and Zoll and a principal investigator for the Abiomed NCSI study and the Chiesi CAMEO registry. Daniel M. Kolansky is a site principal investigator for Cathwoks FFRangio. Arnold H. Seto is a consultant for GE Healthcare. Evan Shlofmitz is a consultant for Abbott Vascular, ACIST Medical, Boston Scientific, Philips, Shockwave Medical, Terumo, and RadiAction. Connie Baumgard is employed by Abbott. Rafa Cavalcante is employed by Boston Scientific. Casey Culbertson is employed by GE Healthcare. Crista Gaalswyk is employed by Boston Scientific. Rob Miltner is employed by Shockwave Medical. Jeremy Moretz is employed by Abiomed/Johnson & Johnson. Jeannie Niebuhr is employed by Abbott. Ann Ollivier is employed by Abiomed. Krish Ramakrishnan is employed by GE Healthcare. Bradley Serwer is employed by Ingenovis Health and Vitalsolution. Nick E. J. West is employed by Shockwave Medical and holds stocks in Abbott and Shockwave Medical. Steve Zizzo is employed by Philips Healthcare. The other authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.